ID   AAAT_HUMAN              Reviewed;         541 AA.
AC   Q15758; A8K9H5; B4DR77; B4DWS4; B7ZB81; D0EYG6; E9PC01; O95720;
AC   Q96RL9; Q9BWQ3; Q9UNP2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2002, sequence version 2.
DT   05-DEC-2018, entry version 185.
DE   RecName: Full=Neutral amino acid transporter B(0);
DE            Short=ATB(0);
DE   AltName: Full=Baboon M7 virus receptor;
DE   AltName: Full=RD114/simian type D retrovirus receptor;
DE   AltName: Full=Sodium-dependent neutral amino acid transporter type 2;
DE   AltName: Full=Solute carrier family 1 member 5;
GN   Name=SLC1A5; Synonyms=ASCT2, M7V1, RDR, RDRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Choriocarcinoma;
RX   PubMed=8702519; DOI=10.1074/jbc.271.31.18657;
RA   Kekuda R., Prasad P.D., Fei Y.-J., Torres-Zamorano V., Sinha S.,
RA   Yang-Feng T.L., Leibach F.H., Ganapathy V.;
RT   "Cloning of the sodium-dependent, broad-scope, neutral amino acid
RT   transporter Bo from a human placental choriocarcinoma cell line.";
RL   J. Biol. Chem. 271:18657-18661(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION AS A VIRAL
RP   RECEPTOR (MICROBIAL INFECTION).
RX   PubMed=10051606; DOI=10.1073/pnas.96.5.2129;
RA   Rasko J.E.J., Battini J.L., Gottschalk R.J., Mazo I., Miller A.D.;
RT   "The RD114/simian type D retrovirus receptor is a neutral amino acid
RT   transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2129-2134(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION AS A VIRAL
RP   RECEPTOR (MICROBIAL INFECTION).
RX   PubMed=10196349;
RA   Tailor C.S., Nouri A., Zhao Y., Takeuchi Y., Kabat D.;
RT   "A sodium-dependent neutral-amino-acid transporter mediates infections
RT   of feline and baboon endogenous retroviruses and simian type D
RT   retroviruses.";
RL   J. Virol. 73:4470-4474(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ouyang D.-Y., Xu L.-H., He X.-H., Zha Q.-B., Guo H., Gao Q.,
RA   Zhang Y.-T.;
RT   "Cloning of ASCT2 cDNA from MCF-7 cells and its expression in B16
RT   cells.";
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT LEU-512.
RC   TISSUE=Esophagus, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-541 (ISOFORM 1), AND ALTERNATIVE
RP   INITIATION.
RX   PubMed=11350958; DOI=10.1074/jbc.M100737200;
RA   Tailor C.S., Marin M., Nouri A., Kavanaugh M.P., Kabat D.;
RT   "Truncated forms of the dual function human ASCT2 neutral amino acid
RT   transporter/retroviral receptor are translationally initiated at
RT   multiple alternative CUG and GUG codons.";
RL   J. Biol. Chem. 276:27221-27230(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=10708449; DOI=10.1128/JVI.74.7.3321-3329.2000;
RA   Blond J.-L., Lavillette D., Cheynet V., Bouton O., Oriol G.,
RA   Chapel-Fernandes S., Mandrand B., Mallet F., Cosset F.-L.;
RT   "An envelope glycoprotein of the human endogenous retrovirus HERV-W is
RT   expressed in the human placenta and fuses cells expressing the type D
RT   mammalian retrovirus receptor.";
RL   J. Virol. 74:3321-3329(2000).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-535, VARIANT
RP   [LARGE SCALE ANALYSIS] LEU-512, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-493, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-493; THR-494; SER-535
RP   AND SER-539, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   FUNCTION, INTERACTION WITH ERVH48-1, AND SUBCELLULAR LOCATION.
RX   PubMed=23492904; DOI=10.1038/srep01462;
RA   Sugimoto J., Sugimoto M., Bernstein H., Jinno Y., Schust D.;
RT   "A novel human endogenous retroviral protein inhibits cell-cell
RT   fusion.";
RL   Sci. Rep. 3:1462-1462(2013).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 158-230, AND SUBUNIT.
RX   PubMed=28424515; DOI=10.1038/nature22064;
RA   Canul-Tec J.C., Assal R., Cirri E., Legrand P., Brier S.,
RA   Chamot-Rooke J., Reyes N.;
RT   "Structure and allosteric inhibition of excitatory amino acid
RT   transporter 1.";
RL   Nature 544:446-451(2017).
RN   [25]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.85 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=29872227; DOI=10.1038/s41594-018-0076-y;
RA   Garaeva A.A., Oostergetel G.T., Gati C., Guskov A., Paulino C.,
RA   Slotboom D.J.;
RT   "Cryo-EM structure of the human neutral amino acid transporter
RT   ASCT2.";
RL   Nat. Struct. Mol. Biol. 25:515-521(2018).
CC   -!- FUNCTION: Sodium-dependent amino acids transporter that has a
CC       broad substrate specificity, with a preference for zwitterionic
CC       amino acids. It accepts as substrates all neutral amino acids,
CC       including glutamine, asparagine, and branched-chain and aromatic
CC       amino acids, and excludes methylated, anionic, and cationic amino
CC       acids (PubMed:8702519, PubMed:29872227). Through binding of the
CC       fusogenic protein syncytin-1/ERVW-1 may mediate trophoblasts
CC       syncytialization, the spontaneous fusion of their plasma
CC       membranes, an essential process in placental development
CC       (PubMed:10708449, PubMed:23492904). {ECO:0000269|PubMed:10708449,
CC       ECO:0000269|PubMed:23492904, ECO:0000269|PubMed:29872227,
CC       ECO:0000269|PubMed:8702519}.
CC   -!- FUNCTION: (Microbial infection) Acts as a cell surface receptor
CC       for Feline endogenous virus RD114. {ECO:0000269|PubMed:10051606,
CC       ECO:0000269|PubMed:10196349}.
CC   -!- FUNCTION: (Microbial infection) Acts as a cell surface receptor
CC       for Baboon M7 endogenous virus. {ECO:0000269|PubMed:10196349}.
CC   -!- FUNCTION: (Microbial infection) Acts as a cell surface receptor
CC       for type D simian retroviruses. {ECO:0000269|PubMed:10196349}.
CC   -!- SUBUNIT: Homotrimer (Probable) (PubMed:29872227). Interacts with
CC       ERVH48-1/suppressyn; may negatively regulate syncytialization
CC       (PubMed:23492904). {ECO:0000269|PubMed:23492904,
CC       ECO:0000269|PubMed:29872227, ECO:0000305|PubMed:28424515}.
CC   -!- INTERACTION:
CC       Q99942:RNF5; NbExp=4; IntAct=EBI-356576, EBI-348482;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8702519,
CC       ECO:0000305|PubMed:29872227}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:29872227}. Melanosome. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC         Comment=A number of isoforms are produced by alternative
CC         initiation. Isoforms start at multiple alternative CUG and GUG
CC         codons. {ECO:0000269|PubMed:11350958};
CC       Name=1;
CC         IsoId=Q15758-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15758-2; Sequence=VSP_046354;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q15758-3; Sequence=VSP_046851;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Placenta, lung, skeletal muscle, kidney,
CC       pancreas, and intestine.
CC   -!- SIMILARITY: Belongs to the dicarboxylate/amino acid:cation
CC       symporter (DAACS) (TC 2.A.23) family. SLC1A5 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U53347; AAC50629.1; -; mRNA.
DR   EMBL; AF102826; AAD09812.1; -; mRNA.
DR   EMBL; AF105423; AAD27806.1; -; mRNA.
DR   EMBL; GQ919058; ACX53626.1; -; mRNA.
DR   EMBL; AK292690; BAF85379.1; -; mRNA.
DR   EMBL; AK299137; BAG61189.1; -; mRNA.
DR   EMBL; AK301661; BAG63136.1; -; mRNA.
DR   EMBL; AK316546; BAH14917.1; -; mRNA.
DR   EMBL; AC008622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471126; EAW57446.1; -; Genomic_DNA.
DR   EMBL; BC000062; AAH00062.1; -; mRNA.
DR   EMBL; AF334818; AAK77026.1; -; mRNA.
DR   CCDS; CCDS12692.1; -. [Q15758-1]
DR   CCDS; CCDS46125.1; -. [Q15758-2]
DR   CCDS; CCDS46126.1; -. [Q15758-3]
DR   RefSeq; NP_001138616.1; NM_001145144.1. [Q15758-3]
DR   RefSeq; NP_001138617.1; NM_001145145.1. [Q15758-2]
DR   RefSeq; NP_005619.1; NM_005628.2. [Q15758-1]
DR   UniGene; Hs.631582; -.
DR   PDB; 5LLM; X-ray; 3.25 A; A=158-230.
DR   PDB; 5LLU; X-ray; 3.32 A; A=158-230.
DR   PDB; 5LM4; X-ray; 3.10 A; A=158-230.
DR   PDB; 5MJU; X-ray; 3.71 A; A=158-230.
DR   PDB; 6GCT; EM; 3.85 A; A/B/C=1-541.
DR   PDBsum; 5LLM; -.
DR   PDBsum; 5LLU; -.
DR   PDBsum; 5LM4; -.
DR   PDBsum; 5MJU; -.
DR   PDBsum; 6GCT; -.
DR   ProteinModelPortal; Q15758; -.
DR   SMR; Q15758; -.
DR   BioGrid; 112401; 73.
DR   IntAct; Q15758; 49.
DR   MINT; Q15758; -.
DR   STRING; 9606.ENSP00000444408; -.
DR   BindingDB; Q15758; -.
DR   ChEMBL; CHEMBL3562162; -.
DR   DrugBank; DB00174; L-Asparagine.
DR   DrugBank; DB00130; L-Glutamine.
DR   GuidetoPHARMACOLOGY; 874; -.
DR   TCDB; 2.A.23.3.3; the dicarboxylate/amino acid:cation (na(+) or h(+)) symporter (daacs) family.
DR   GlyConnect; 1562; -.
DR   iPTMnet; Q15758; -.
DR   PhosphoSitePlus; Q15758; -.
DR   SwissPalm; Q15758; -.
DR   BioMuta; SLC1A5; -.
DR   DMDM; 21542389; -.
DR   EPD; Q15758; -.
DR   MaxQB; Q15758; -.
DR   PaxDb; Q15758; -.
DR   PeptideAtlas; Q15758; -.
DR   PRIDE; Q15758; -.
DR   ProteomicsDB; 60744; -.
DR   DNASU; 6510; -.
DR   Ensembl; ENST00000412532; ENSP00000397924; ENSG00000105281. [Q15758-3]
DR   Ensembl; ENST00000434726; ENSP00000406532; ENSG00000105281. [Q15758-2]
DR   Ensembl; ENST00000542575; ENSP00000444408; ENSG00000105281. [Q15758-1]
DR   GeneID; 6510; -.
DR   KEGG; hsa:6510; -.
DR   UCSC; uc002pfr.4; human. [Q15758-1]
DR   CTD; 6510; -.
DR   DisGeNET; 6510; -.
DR   EuPathDB; HostDB:ENSG00000105281.12; -.
DR   GeneCards; SLC1A5; -.
DR   H-InvDB; HIX0015262; -.
DR   HGNC; HGNC:10943; SLC1A5.
DR   HPA; HPA035239; -.
DR   HPA; HPA035240; -.
DR   MIM; 109190; gene.
DR   neXtProt; NX_Q15758; -.
DR   OpenTargets; ENSG00000105281; -.
DR   PharmGKB; PA35830; -.
DR   eggNOG; KOG3787; Eukaryota.
DR   eggNOG; COG1301; LUCA.
DR   GeneTree; ENSGT00940000159485; -.
DR   HOGENOM; HOG000208776; -.
DR   HOVERGEN; HBG000080; -.
DR   InParanoid; Q15758; -.
DR   KO; K05616; -.
DR   OMA; NPYTFLW; -.
DR   OrthoDB; EOG091G0UCE; -.
DR   PhylomeDB; Q15758; -.
DR   TreeFam; TF315206; -.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   ChiTaRS; SLC1A5; human.
DR   GeneWiki; SLC1A5; -.
DR   GenomeRNAi; 6510; -.
DR   PRO; PR:Q15758; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105281; Expressed in 220 organ(s), highest expression level in urinary bladder.
DR   CleanEx; HS_SLC1A5; -.
DR   ExpressionAtlas; Q15758; baseline and differential.
DR   Genevisible; Q15758; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015186; F:L-glutamine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015194; F:L-serine transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015175; F:neutral amino acid transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0010585; P:glutamine secretion; IEA:Ensembl.
DR   GO; GO:0006868; P:glutamine transport; IDA:UniProtKB.
DR   GO; GO:1903803; P:L-glutamine import across plasma membrane; IEA:Ensembl.
DR   GO; GO:0015804; P:neutral amino acid transport; TAS:ProtInc.
DR   GO; GO:0070207; P:protein homotrimerization; IDA:UniProtKB.
DR   Gene3D; 1.10.3860.10; -; 1.
DR   InterPro; IPR001991; Na-dicarboxylate_symporter.
DR   InterPro; IPR018107; Na-dicarboxylate_symporter_CS.
DR   InterPro; IPR036458; Na:dicarbo_symporter_sf.
DR   Pfam; PF00375; SDF; 1.
DR   SUPFAM; SSF118215; SSF118215; 1.
DR   PROSITE; PS00713; NA_DICARBOXYL_SYMP_1; 1.
DR   PROSITE; PS00714; NA_DICARBOXYL_SYMP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Alternative splicing; Amino-acid transport; Cell membrane;
KW   Complete proteome; Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Sodium; Symport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    541       Neutral amino acid transporter B(0).
FT                                /FTId=PRO_0000202082.
FT   TOPO_DOM      1     51       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     52     81       Helical; Name=1.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM     82     94       Extracellular. {ECO:0000305}.
FT   TRANSMEM     95    116       Helical; Name=2.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    117    130       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    131    153       Helical; Name=3.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    154    224       Extracellular. {ECO:0000305}.
FT   TRANSMEM    225    248       Helical; Name=4.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    249    257       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    258    285       Helical; Name=5.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    286    306       Extracellular. {ECO:0000305}.
FT   TRANSMEM    307    328       Helical; Name=6.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    329    333       Cytoplasmic. {ECO:0000305}.
FT   INTRAMEM    334    364       Discontinuously helical.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    365    373       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    374    400       Helical; Name=7.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    401    413       Extracellular. {ECO:0000305}.
FT   INTRAMEM    414    447       Discontinuously helical.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    448    460       Extracellular. {ECO:0000305}.
FT   TRANSMEM    461    482       Helical; Name=8.
FT                                {ECO:0000305|PubMed:29872227}.
FT   TOPO_DOM    483    541       Cytoplasmic. {ECO:0000305}.
FT   METAL       382    382       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:O59010}.
FT   METAL       384    384       Sodium 2; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P43003}.
FT   METAL       386    386       Sodium 1. {ECO:0000250|UniProtKB:O59010}.
FT   METAL       471    471       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:O59010}.
FT   METAL       475    475       Sodium 1. {ECO:0000250|UniProtKB:O59010}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     493    493       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     494    494       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     503    503       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     535    535       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     539    539       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   VAR_SEQ       1    228       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046851.
FT   VAR_SEQ       1    203       MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGS
FT                                RDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALG
FT                                PERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGA
FT                                LGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINA
FT                                SVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRS
FT                                -> M (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046354.
FT   VARIANT      17     17       P -> A (in dbSNP:rs3027956).
FT                                /FTId=VAR_020439.
FT   VARIANT     512    512       V -> L (in dbSNP:rs3027961).
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_013517.
FT   CONFLICT     18     24       TANGGLA -> PPTGAWQ (in Ref. 1; AAC50629).
FT                                {ECO:0000305}.
FT   CONFLICT     44     44       Q -> L (in Ref. 1; AAC50629).
FT                                {ECO:0000305}.
FT   CONFLICT     84     87       ERLS -> GALE (in Ref. 1; AAC50629).
FT                                {ECO:0000305}.
FT   CONFLICT    341    341       V -> A (in Ref. 5; BAH14917).
FT                                {ECO:0000305}.
FT   CONFLICT    453    453       I -> V (in Ref. 2; AAD09812).
FT                                {ECO:0000305}.
FT   CONFLICT    460    460       D -> G (in Ref. 2; AAD09812).
FT                                {ECO:0000305}.
FT   CONFLICT    463    463       V -> A (in Ref. 2; AAD09812).
FT                                {ECO:0000305}.
FT   CONFLICT    508    508       D -> G (in Ref. 2; AAD09812).
FT                                {ECO:0000305}.
FT   HELIX        54     62       {ECO:0000244|PDB:5LM4}.
FT   HELIX        66     69       {ECO:0000244|PDB:5LM4}.
FT   HELIX       104    107       {ECO:0000244|PDB:5LM4}.
FT   HELIX       180    191       {ECO:0000244|PDB:5LM4}.
FT   HELIX       196    199       {ECO:0000244|PDB:5LM4}.
FT   STRAND      202    204       {ECO:0000244|PDB:5LM4}.
FT   STRAND      225    228       {ECO:0000244|PDB:5LM4}.
FT   HELIX       231    237       {ECO:0000244|PDB:5LM4}.
FT   HELIX       239    245       {ECO:0000244|PDB:5LM4}.
FT   HELIX       254    261       {ECO:0000244|PDB:5LM4}.
FT   HELIX       266    270       {ECO:0000244|PDB:5LM4}.
FT   HELIX       324    329       {ECO:0000244|PDB:5LM4}.
FT   HELIX       476    480       {ECO:0000244|PDB:5LM4}.
SQ   SEQUENCE   541 AA;  56598 MW;  AD61C789CCFFE934 CRC64;
     MVADPPRDSK GLAAAEPTAN GGLALASIED QGAAAGGYCG SRDQVRRCLR ANLLVLLTVV
     AVVAGVALGL GVSGAGGALA LGPERLSAFV FPGELLLRLL RMIILPLVVC SLIGGAASLD
     PGALGRLGAW ALLFFLVTTL LASALGVGLA LALQPGAASA AINASVGAAG SAENAPSKEV
     LDSFLDLARN IFPSNLVSAA FRSYSTTYEE RNITGTRVKV PVGQEVEGMN ILGLVVFAIV
     FGVALRKLGP EGELLIRFFN SFNEATMVLV SWIMWYAPVG IMFLVAGKIV EMEDVGLLFA
     RLGKYILCCL LGHAIHGLLV LPLIYFLFTR KNPYRFLWGI VTPLATAFGT SSSSATLPLM
     MKCVEENNGV AKHISRFILP IGATVNMDGA ALFQCVAAVF IAQLSQQSLD FVKIITILVT
     ATASSVGAAG IPAGGVLTLA IILEAVNLPV DHISLILAVD WLVDRSCTVL NVEGDALGAG
     LLQNYVDRTE SRSTEPELIQ VKSELPLDPL PVPTEEGNPL LKHYRGPAGD ATVASEKESV
     M
//
